Why Vera Therapeutics Stock Is Jumping on New Kidney Drug Trial Results
Vera Therapeutics takes a step toward securing full Food and Drug Administration approval for its injectable kidney drug, Trutakna. Continue Reading
YENOM NOTICIAS
Qué está moviendo el mercado.
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
FDA Fast-Tracks Review of Some Psychedelic Drugs. This Stock Is Set to Benefit.
Compass Pathways, the developer of synthetic psilocybin, announced it had received a government voucher. Continue Reading
Assessing Whether Otsuka Holdings (TSE:4578) Is Overvalued After Recent Share Price Momentum
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Event context and recent share performance Otsuka Holdings (TSE:4578) has been on investors’ radar…
Biotech Stocks Facing FDA Decision In February 2026
(RTTNews) - As January 2026 comes to a close, it is time to reflect on the regulatory developments of the month and look ahead to what's in store in February. On January 13, 2026, Sentynl Therapeutics' Zycubo secured FDA approval, becoming…
Recent Price Trend in Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTSKY) is Your Friend, Here's Why
Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it. Often, t…
EU Approves DAWNZERA For Hereditary Angioedema, Says Ionis And Otsuka
(RTTNews) - Ionis Pharmaceuticals, Inc. (IONS) and Otsuka Pharmaceutical Co., Ltd. on Wednesday said the European Commission has approved Dawnzera to prevent repeated attacks of hereditary angioedema (HAE) in people aged 12 and older. HAE…
Underactive Bladder Syndrome Market to Observe Stunning Growth at a CAGR of 22.1% During the Forecast Period (2025-2034) | DelveInsight
The underactive bladder syndrome market is expected to grow steadily, driven by an aging global population and rising prevalence of neurogenic and chronic conditions affecting bladder function. Increasing awareness and improved diagnostic…
Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTSKY) Is a Great Choice for 'Trend' Investors, Here's Why
Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it. The tren…
Here's Why Momentum in Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTSKY) Should Keep going
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy. T…
JFCR, NEC, And Taiho Launch Joint Research To Develop Shared Neoantigen Cancer Vaccines
(RTTNews) - The Japanese Foundation for Cancer Research (JFCR), NEC Corporation, and Taiho Pharmaceutical Co., Ltd. have entered into a joint research agreement to develop new cancer vaccines using whole-genome information. This project is…
Otsuka gains FDA approval for sibeprenlimab for proteinuria reduction
[Fda Approved Stamp] atakan * The U.S. FDA has approved Otsuka Pharmaceutical's (OTCPK:OTSKF [https://seekingalpha.com/symbol/OTSKF]) Voyxact (sibeprenlimab) for proteinuria reduction in individuals with primary immunoglobulin A nephropath…
FDA Grants Accelerated Approval For Otsuka's VOYXACT In IgAN
(RTTNews) - Otsuka Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Development & Commercialization, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of VOYXACT (sibeprenlimab-szsi). The th…
Sanofi, Lilly among winners of EU drug recommendations this week
[Flag of European Union Waving Background] forest_strider/iStock via Getty Images During a meeting this week, an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed 10 new medicines for approval, including…
Otsuka 9-month Profit Rises; Revenue Up 5.1%
(RTTNews) - Otsuka Holdings Co. (4578.T) reported that its nine month profit attributable to owners of the company was 297.7 billion yen, an increase of 55.3% from last year. Earnings per share was 560.81 yen compared to 353.33 yen. Busine…
Taiho Pharma, Haihe Biopharma Enter Into Agreement For Ovarian Cancer Drug Candidate Risovalisib
(RTTNews) - Taiho Pharma, a subsidiary of Otsuka Holdings Co., Ltd. (4578.T,OTSKF) and Haihe Biopharma Co., Ltd., a Chinese biopharmaceutical company, announced on Thursday that they have entered into an exclusive license agreement for PI3…
Trump’s 100% drug tariffs send pharma stocks lower
[Many different pills on pink background. Prescription pills and vitamins. Flat lay and space for text.] Baurzhan Ibrashev European and Asian pharmaceutical stocks fell Friday after President Donald Trump unveiled sweeping new tariffs, inc…
Otsuka Holdings (TSE:4578): Is the Recent Share Price Rise Backed by Fundamentals?
Otsuka Holdings (TSE:4578) has been on investors’ radar lately, and for good reason. There isn’t a blockbuster announcement making headlines this week, but stock watchers have noticed a steady climb that is hard to ignore. When a company o…
Trump administration moves to regulate pharmaceutical ads on TV and social media
[Medicine pack set in shopping cart for medicine buying market consumer products retail in pharmacy drugstore with copy space for advertising.] coffeekai/iStock via Getty Images U.S. President Donald Trump signed a memorandum on Tuesday th…
Otsuka’s PTSD therapy draws efficacy concerns at FDA ahead of AdCom meeting
[A pill bottle with a head on it and the words Post Traumatic Stress Disorder written below it] Inna Kot/iStock via Getty Images The FDA staffers on Wednesday cited efficacy issues related to a combination regimen involving brexpiprazole,…
Corrections & Amplifications
The name of the GBU-57 bomb, also called the Massive Ordnance Penetrator or MOP, was incorrectly listed as MOPS GBU-57 in a graphic with a World News article on Wednesday about the weapon, which is known as a bunker buster. Crystal Geyser…
White House reportedly eyeing restrictions to prescription drug advertising
[The White House in Washington DC] lucky-photographer The U.S. government is looking for ways to restrict the pharma sector’s direct-to-consumer advertising to make it more difficult and costly for companies to run advertisements directly…
Biotech Stock Vera Is Slumping After Monster Gain
Vera Therapeutics stock rocketed nearly 70% on Monday on upbeat data for a kidney-disease trial. Shares are tumbling Friday on a rival’s study. Continue Reading View Comments
Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension
World Hypertension Day's focus on High Blood Pressure Awareness, Management and Control highlights Importance of New Therapies, like Ultrasound Renal Denervation from Recor Medical PALO ALTO, Calif., FRANKFURT, Germany, May 17, 2025 /PRNew…
Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices
Novo Nordisk, which generates around 60% of its sales in the U.S., is among the biggest losers in early European trade. Continue Reading View Comments
Trump's Plan to Cut Drug Prices Hits Pharma Stocks
Drugmakers' shares fell after President Trump said he would sign an executive order to lower the cost of prescription drugs. Shares of Japan's Daiichi Sankyo, which gets about a third of revenue from the U.S., dropped more than 8% in Tokyo…
Trump Drug Plan Hits Asian Pharma Stocks
Shares of Asian drugmakers fell after President Trump said he would sign an executive order to lower the cost of prescription drugs. Shares of Japan's Daiichi Sankyo, which gets about a third of its revenue from the U.S., dropped more than…
Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific
(Bloomberg) -- Otsuka Holdings Co. is considering options for its holding in Hong Kong-listed MicroPort Scientific Corp., including selling its stake in the medical device maker, according to people familiar with the situation. Most Read f…
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Ionis Pharmaceuticals IONS has entered into a licensing agreement with Otsuka Pharmaceutical. Per the terms, Otsuka will acquire exclusive rights to market its investigational late-stage hereditary angioedema (HAE) therapy, donidalorsen, i…
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation Tuesday, IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agit…
Ionis (IONS) Out Licenses Europe Rights for HAE Drug to Otsuka
Ionis Pharmaceuticals IONS signed a license agreement with Otsuka Pharmaceutical. Per the terms, Otsuka Pharmaceutical will acquire exclusive rights to market its investigational late-stage hereditary angioedema (HAE) therapy, donidalorsen…
Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy
Innovative new treatment option for patients with uncontrolled hypertension now available in the United States PALO ALTO, Calif., November 10, 2023--(BUSINESS WIRE)--Recor Medical, Inc. ("Recor") and its parent company, Otsuka Medical Devi…
Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S. PALO ALTO, Calif., November 08, 2023--(BUSINESS WIRE)--Recor Medical, Inc. ("Recor") and its par…
US FDA approves Otsuka's blood pressure treatment device for use
Nov 8 (Reuters) - The U.S. Food and Drug Administration (FDA) approved the use of a device made by an Otsuka Holdings unit in a type of surgery to treat high blood pressure, the company said on Wednesday. The approval for Paradise Ultrasou…
Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023
Analysis shows a maintained blood pressure lowering effect with fewer added medications following treatment with the Paradise Ultrasound Renal Denervation system PALO ALTO, Calif., October 26, 2023--(BUSINESS WIRE)--Recor Medical, Inc. ("R…
U.S. Stocks Open Mostly Higher As S&P 500 Heads For Third Straight Week Of Losses
U.S. stocks opened mostly higher but were on pace for weekly losses after a rise in Treasury yields following the Federal Reserve’s policy meeting. Continue reading
Nikkei Falls 0.5%, Dragged by Retail, Pharma Stocks
Japanese stocks ended lower, dragged by falls in retail and pharmaceutical stocks, as concerns persist about inflation and higher borrowing costs. Continue reading